Stock Report

Morepen Laboratories consolidated Q1FY23 PAT falls to Rs. 5.62 crores

Posted On : 2022-07-29 15:00:54( TIMEZONE : IST )

Morepen Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 303.3149 crores during the period ended June 30, 2022 as compared to Rs. 371.4634 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 5.6299 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 12.3224 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.11 for the period ended June 30, 2022 as compared to Rs. 0.24 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹303.3149 crs	₹371.4634 crs	-18.35%
Net Profit	₹5.6299 crs	₹12.3224 crs	-54.31%
EPS	₹0.11	₹0.24	-54.17%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs.303.3149 crores during the period ended June 30, 2022 as compared to Rs.388.3133 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.5.6299 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.30.4741 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.11 for the period ended June 30, 2022 as compared to Rs.0.59 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹303.3149 crs	₹388.3133 crs	-21.89%
Net Profit	₹5.6299 crs	₹30.4741 crs	-81.53%
EPS	₹0.11	₹0.59	-81.36%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 36.95 as compared to the previous close of Rs. 37.55. The total number of shares traded during the day was 237690 in over 2449 trades.

The stock hit an intraday high of Rs. 37.90 and intraday low of 36.80. The net turnover during the day was Rs. 8827130.00.